Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Human Growth Hormone

Recombinant protein · Agonist of growth hormone receptor (GHR) · developed by BioMarin Pharmaceutical

Phase 2 Most advanced trial
BMRN Developer
1 Registered trials

What is Human Growth Hormone?

Human Growth Hormone (somatotropin) is a commercial product containing somatotropin, a recombinant growth hormone.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Recombinant protein
Targets
growth hormone receptor (GHR)
Mechanism
Agonist of growth hormone receptor (GHR)
Therapy area
Endocrine
Developer
BioMarin Pharmaceutical (BMRN)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06382155 Phase 2 Idiopathic Short Stature Recruiting BMRN

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Idiopathic Short Stature

Other drugs acting on GHR

More from BioMarin Pharmaceutical

Sources

Updated Nov 8, 2026. Something wrong or missing? Report it on the BMRN page.

Follow BMRN, the company behind Human Growth Hormone

See BMRN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

BMRN catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.